Tecan Group Resultados de beneficios anteriores
Pasado controles de criterios 0/6
Los beneficios de Tecan Group han disminuido a una tasa media anual de -25.5%, mientras que en la industria Life Sciences los beneficios crecieron en un 3.6% anualmente. Los ingresos han ido creciendo a una tasa media de 0.9% al año.
Información clave
-25.46%
Tasa de crecimiento de los beneficios
-26.64%
Tasa de crecimiento del BPA
| Crecimiento de la industria Life Sciences | 17.57% |
| Tasa de crecimiento de los ingresos | 0.88% |
| Rentabilidad financiera | -9.61% |
| Margen neto | -12.54% |
| Próxima actualización de resultados | 11 Aug 2026 |
Actualizaciones de resultados anteriores recientes
Recent updates
Actualización de narrativa • Jun 14
TECN: Reset CHF 205 Goal Will Support Future Earnings Re Rating
Analysts have reduced their price target for Tecan Group from CHF 335.08 to CHF 205.00, citing updated assumptions for revenue growth, profit margins and future P/E multiples, along with recent Street research cuts from CHF 10 and CHF 1. Analyst Commentary Recent Street research has focused on recalibrating Tecan Group’s valuation framework, with price targets adjusted to reflect updated views on revenue growth, margins and P/E multiples.
Actualización de narrativa • May 31
TECN: Reduced P/E Expectations Will Limit Perceived Upside Potential
Analysts have trimmed their price targets on Tecan Group by CHF 1 to CHF 10 in recent updates. This reflects revised assumptions around discount rates, profit margins and future P/E expectations.Actualización de narrativa • May 02
TECN: Updated Discount Assumptions Will Shape Perceived Upside Potential
Tecan Group's analyst price target has been reduced by CHF 1 to CHF 136, as analysts factor in updated discount rate and valuation assumptions, along with modest adjustments to revenue growth, profit margin and future P/E inputs. Analyst Commentary Recent research points to a more cautious tone around Tecan Group, with reduced price targets reflecting reassessed assumptions on growth, profitability and valuation multiples.
Actualización de narrativa • Apr 18
TECN: AI Lab Collaboration And Execution Discipline Will Support Future Earnings
The analyst price target for Tecan Group has shifted slightly to around CHF 167, with recent CHF 1 and CHF 17 target reductions from different firms. These moves have led analysts to fine tune assumptions on discount rate, revenue growth, profit margin and future P/E, without changing the overall valuation picture in a major way.Actualización de narrativa • Apr 03
TECN: Mixed Research Views And 2026 Guidance Shape Forward Expectations
Analysts have trimmed their average price target on Tecan Group to CHF 205, a CHF 17 reduction from recent levels. This reflects updated views on discount rates, revenue growth, profit margins and future P/E assumptions following mixed target moves across the Street.Actualización de narrativa • Mar 20
TECN: AI Lab Collaboration Will Support Forward Efficiency Gains And Earnings
The updated analyst price target for Tecan Group moves to CHF 166.50 from CHF 192.57, reflecting mixed Street views as some analysts trim targets while others highlight support from higher assumed revenue growth and a slightly lower future P/E multiple. Analyst Commentary Recent Street research on Tecan Group points to a split view, with some analysts trimming price targets and others turning more constructive on the shares.Actualización de narrativa • Mar 05
TECN: Mixed Research Views And Investor Day Outlook Shape Future Expectations
Analysts have trimmed their price target for Tecan Group to CHF 137.00 from CHF 165.20, reflecting updated assumptions around discount rates, revenue growth, profit margins and future P/E. Recent research also includes both a Morgan Stanley target cut and target and rating adjustments from other firms.Actualización de narrativa • Feb 19
TECN: Recent Upgrade And CHF 205 Goal Will Support Higher Long Term P/E
Analysts have nudged their price targets on Tecan Group slightly lower, with moves such as Morgan Stanley trimming its target by CHF 5 and others, including Bernstein and Berenberg, adjusting their outlooks. These revisions have led to only marginal changes in modeled fair value, discount rate, revenue growth, profit margin, and future P/E assumptions.Actualización de narrativa • Feb 05
TECN: CFO Transition And Execution Will Support Higher Long Term P/E Potential
Analysts have nudged their price expectations for Tecan Group slightly higher, with the updated fair value estimate moving from CHF 334.71 to about CHF 335.08. This reflects small model adjustments to growth, margins and long term P/E assumptions after recent mixed target moves from banks that both lowered and raised their CHF based price targets.Actualización de narrativa • Jan 22
TECN: Execution And CFO Transition Will Support Upgraded Outlook And Medium Term Upside
Narrative Update The analyst price target for Tecan Group has been revised to CHF 205 from CHF 200. Analysts cite updated assumptions on growth, profitability and a higher future P/E multiple as the main factors behind this change.Actualización de narrativa • Jan 08
TECN: Efficiency Gains And Gradual Market Recovery Will Support Forward Earnings
Analysts have trimmed their price target on Tecan Group to about CHF 193 from around CHF 202, reflecting slightly lower fair value estimates, supported by recent target reductions such as the move to CHF 170 cited in Street research. Analyst Commentary Recent Street commentary around Tecan Group points to a more cautious stance, with price targets being reset closer to CHF 170, which sits below the trimmed average around CHF 193.Artículo de análisis • Dec 23
Does Tecan Group (VTX:TECN) Have A Healthy Balance Sheet?
Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...Actualización de narrativa • Dec 14
TECN: Medium Term Execution And CFO Transition Will Support Future Upside Potential
Analysts have lowered their price target on Tecan Group to CHF 170 from CHF 177, reflecting a slightly higher discount rate despite modestly improved revenue growth and profit margin expectations. Analyst Commentary Bullish analysts acknowledge the modest reduction in the price target but view the revised CHF 170 level as still supportive of upside potential from current trading levels, given improving fundamentals and execution.Actualización de narrativa • Nov 30
TECN: Efficiency Gains And Market Recovery Will Drive Forward Earnings Improvements
Analysts have reduced their price target for Tecan Group from CHF 177 to CHF 170. They cited revised market assumptions and modest adjustments to key financial forecasts as reasons for this change.Actualización de narrativa • Nov 16
TECN: Automation Demand And Partnerships Will Drive Earnings Recovery After 2026
Tecan Group: Analyst Price Target Reduced on Updated Outlook Analysts have lowered their fair value estimate for Tecan Group from CHF 205.98 to CHF 202.48. They cited slightly higher discount rates and tempered expectations for revenue growth and profit margins as reasons for the change.Artículo de análisis • Nov 06
Tecan Group AG's (VTX:TECN) Intrinsic Value Is Potentially 90% Above Its Share Price
Key Insights Using the 2 Stage Free Cash Flow to Equity, Tecan Group fair value estimate is CHF261 Tecan Group's CHF138...Actualización de narrativa • Nov 01
TECN: Resilient Demand And Share Repurchase Program Will Drive Shareholder Value
The analyst price target for Tecan Group has been revised downward from CHF 177 to CHF 170. Analysts cite slightly softer revenue growth expectations and a modest increase in the discount rate in their updated assessments.Artículo de análisis • Oct 22
Should You Investigate Tecan Group AG (VTX:TECN) At CHF150?
Tecan Group AG ( VTX:TECN ), is not the largest company out there, but it saw significant share price movement during...Actualización de narrativa • Oct 18
Advanced Automation And Personalized Medicine Will Shape Healthcare's Future
Tecan Group's updated analyst fair value price target has been revised downward from CHF 215.73 to CHF 207.23. This change reflects cautious analyst views amid slower revenue growth and tightened profit margin expectations.Actualización de narrativa • Oct 04
Advanced Automation And Personalized Medicine Will Shape Healthcare's Future
Analysts have adjusted their price target for Tecan Group downward, reducing the fair value estimate from CHF 220.47 to CHF 215.73. This change is due to a slight increase in the discount rate, although forecasts for revenue growth and profit margins have improved.Actualización de narrativa • Sep 05
Advanced Automation And Personalized Medicine Will Shape Healthcare's Future
Analysts have lowered their outlook for Tecan Group due to concerns over near-term margin pressure, cautious end-market demand, and delayed recovery in key segments, though the consensus price target remained unchanged at CHF220.47. Analyst Commentary Cautious sentiment due to anticipation of "soft" first-half financial results impacting near-term performance.Artículo de análisis • Sep 04
Tecan Group (VTX:TECN) Has A Pretty Healthy Balance Sheet
David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...Artículo de análisis • Aug 20
Weak Statutory Earnings May Not Tell The Whole Story For Tecan Group (VTX:TECN)
SWX:TECN 1 Year Share Price vs Fair Value Explore Tecan Group's Fair Values from the Community and select yours The...Artículo de análisis • Aug 08
Tecan Group AG's (VTX:TECN) Intrinsic Value Is Potentially 81% Above Its Share Price
Key Insights Tecan Group's estimated fair value is CHF281 based on 2 Stage Free Cash Flow to Equity Current share price...Artículo de análisis • Jul 21
Why We're Not Concerned About Tecan Group AG's (VTX:TECN) Share Price
When close to half the companies in Switzerland have price-to-earnings ratios (or "P/E's") below 20x, you may consider...Artículo de análisis • May 28
At CHF170, Is Tecan Group AG (VTX:TECN) Worth Looking At Closely?
While Tecan Group AG ( VTX:TECN ) might not have the largest market cap around , it saw a significant share price rise...Artículo de análisis • Apr 24
Is Tecan Group AG (VTX:TECN) Trading At A 26% Discount?
Key Insights Tecan Group's estimated fair value is CHF199 based on 2 Stage Free Cash Flow to Equity Tecan Group is...Artículo de análisis • Apr 08
Tecan Group AG (VTX:TECN) Shares Slammed 25% But Getting In Cheap Might Be Difficult Regardless
To the annoyance of some shareholders, Tecan Group AG ( VTX:TECN ) shares are down a considerable 25% in the last...Artículo de análisis • Apr 04
Here's Why Shareholders Should Examine Tecan Group AG's (VTX:TECN) CEO Compensation Package More Closely
Key Insights Tecan Group will host its Annual General Meeting on 10th of April Total pay for CEO Achim von Leoprechting...Artículo de análisis • Apr 01
Is Tecan Group (VTX:TECN) Using Too Much Debt?
David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...
Nueva narrativa • Mar 16
Expansion Into South Korea And FDA Approval To Support Future High-Value Medical Device Production
Expansion into South Korea and FDA approval in Malaysia bolster Tecan's production and revenue growth potential in medical devices.Artículo de análisis • Jan 12
Tecan Group AG's (VTX:TECN) Share Price Could Signal Some Risk
When close to half the companies in Switzerland have price-to-earnings ratios (or "P/E's") below 20x, you may consider...Artículo de análisis • Dec 21
A Look At The Fair Value Of Tecan Group AG (VTX:TECN)
Key Insights Using the 2 Stage Free Cash Flow to Equity, Tecan Group fair value estimate is CHF231 With CHF198 share...Artículo de análisis • Oct 09
Tecan Group AG's (VTX:TECN) P/E Still Appears To Be Reasonable
With a price-to-earnings (or "P/E") ratio of 33.7x Tecan Group AG ( VTX:TECN ) may be sending very bearish signals at...Artículo de análisis • Sep 21
These 4 Measures Indicate That Tecan Group (VTX:TECN) Is Using Debt Reasonably Well
Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...Artículo de análisis • Aug 16
Earnings Report: Tecan Group AG Missed Revenue Estimates By 8.8%
It's been a sad week for Tecan Group AG ( VTX:TECN ), who've watched their investment drop 13% to CHF280 in the week...Artículo de análisis • Jun 14
Is Tecan Group (VTX:TECN) Using Too Much Debt?
Warren Buffett famously said, 'Volatility is far from synonymous with risk.' So it might be obvious that you need to...Artículo de análisis • Apr 20
Calculating The Fair Value Of Tecan Group AG (VTX:TECN)
Key Insights Tecan Group's estimated fair value is CHF409 based on 2 Stage Free Cash Flow to Equity Current share price...Desglose de ingresos y gastos
Desglose de ingresos y gastos
Cómo gana y gasta dinero Tecan Group. Basado en los últimos beneficios reportados, en base a los últimos doce meses (LTM).
Historial de beneficios e ingresos
| Fecha | Ingresos | Beneficios | Gastos G+A | Gastos de I+D |
|---|---|---|---|---|
| 31 Dec 25 | 882 | -111 | 200 | 67 |
| 30 Sep 25 | 895 | -24 | 191 | 66 |
| 30 Jun 25 | 907 | 63 | 182 | 71 |
| 31 Mar 25 | 920 | 65 | 183 | 70 |
| 31 Dec 24 | 934 | 68 | 184 | 63 |
| 30 Sep 24 | 967 | 85 | 188 | 63 |
| 30 Jun 24 | 1,000 | 101 | 192 | 64 |
| 31 Mar 24 | 1,037 | 117 | 192 | 67 |
| 31 Dec 23 | 1,074 | 132 | 192 | 70 |
| 30 Sep 23 | 1,088 | 120 | 198 | 74 |
| 30 Jun 23 | 1,102 | 109 | 205 | 78 |
| 31 Mar 23 | 1,123 | 115 | 209 | 78 |
| 31 Dec 22 | 1,144 | 121 | 214 | 78 |
| 30 Sep 22 | 1,110 | 113 | 212 | 79 |
| 30 Jun 22 | 1,077 | 105 | 210 | 79 |
| 31 Mar 22 | 1,012 | 113 | 201 | 76 |
| 31 Dec 21 | 947 | 122 | 192 | 72 |
| 30 Sep 21 | 911 | 136 | 192 | 70 |
| 30 Jun 21 | 875 | 150 | 191 | 68 |
| 31 Mar 21 | 803 | 127 | 182 | 65 |
| 31 Dec 20 | 731 | 104 | 172 | 62 |
| 30 Sep 20 | 691 | 94 | 160 | 59 |
| 30 Jun 20 | 651 | 84 | 149 | 56 |
| 31 Mar 20 | 644 | 79 | 149 | 58 |
| 31 Dec 19 | 637 | 73 | 149 | 60 |
| 30 Sep 19 | 627 | 70 | 150 | 59 |
| 30 Jun 19 | 616 | 67 | 151 | 59 |
| 31 Mar 19 | 605 | 69 | 146 | 55 |
| 31 Dec 18 | 594 | 71 | 141 | 51 |
| 30 Sep 18 | 582 | 70 | 139 | 50 |
| 30 Jun 18 | 570 | 69 | 138 | 49 |
| 31 Mar 18 | 559 | 67 | 137 | 50 |
| 31 Dec 17 | 549 | 66 | 136 | 50 |
| 30 Sep 17 | 536 | 62 | 132 | 49 |
| 30 Jun 17 | 523 | 57 | 129 | 48 |
| 31 Mar 17 | 515 | 56 | 127 | 47 |
| 31 Dec 16 | 506 | 55 | 125 | 47 |
| 30 Sep 16 | 491 | 55 | 123 | 45 |
| 30 Jun 16 | 476 | 55 | 120 | 43 |
| 31 Mar 16 | 458 | 56 | 115 | 41 |
| 31 Dec 15 | 440 | 57 | 110 | 40 |
| 30 Sep 15 | 434 | 52 | 108 | 41 |
Ingresos de calidad: TECN actualmente no es rentable.
Margen de beneficios creciente: TECN actualmente no es rentable.
Análisis del flujo de caja libre vs. Beneficios
Análisis del crecimiento de los beneficios en el pasado
Tendencia de beneficios: TECN no es rentable, y las pérdidas han aumentado en los últimos 5 años a un ritmo de 25.5% al año.
Acelerando crecimiento: No se puede comparar el crecimiento de los beneficios de TECN en el último año con su promedio de 5 años, ya que actualmente no es rentable.
Beneficios vs. Industria: TECN no es rentable, por lo que resulta difícil comparar el crecimiento de sus beneficios en el último año con el de la industria Life Sciences (5.4%).
Rentabilidad financiera
Alta ROE: TECN tiene una rentabilidad financiera negativa (-9.61%), ya que actualmente no es rentable.
Rentabilidad económica
Rendimiento del capital invertido
Descubre empresas con buenos resultados en el pasado
Análisis de la empresa y estado de los datos financieros
| Datos | Última actualización (huso horario UTC) |
|---|---|
| Análisis de la empresa | 2026/06/30 00:13 |
| Precio de las acciones al final del día | 2026/06/30 00:00 |
| Beneficios | 2025/12/31 |
| Ingresos anuales | 2025/12/31 |
Fuentes de datos
Los datos utilizados en nuestro análisis de empresas proceden de S&P Global Market Intelligence LLC. Los siguientes datos se utilizan en nuestro modelo de análisis para generar este informe. Los datos están normalizados, lo que puede introducir un retraso desde que la fuente está disponible.
| Paquete | Datos | Marco temporal | Ejemplo Fuente EE.UU. * |
|---|---|---|---|
| Finanzas de la empresa | 10 años |
| |
| Estimaciones del consenso de analistas | +3 años |
|
|
| Precios de mercado | 30 años |
| |
| Propiedad | 10 años |
| |
| Gestión | 10 años |
| |
| Principales avances | 10 años |
|
* Ejemplo para valores de EE.UU., para no EE.UU. se utilizan formularios y fuentes normativas equivalentes.
A menos que se especifique lo contrario, todos los datos financieros se basan en un periodo anual, pero se actualizan trimestralmente. Esto se conoce como datos de los últimos doce meses (TTM) o de los últimos doce meses (LTM). Más información.
Modelo de análisis y copo de nieve
Los detalles del modelo de análisis utilizado para generar este informe están disponibles en nuestra página de Github, también contamos con guías sobre cómo utilizar nuestros informes y tutoriales en Youtube.
Conozca al equipo de talla mundial que diseñó y construyó el modelo de análisis Simply Wall St.
Métricas industriales y sectoriales
Simply Wall St calcula cada 6 horas nuestras métricas sectoriales y de sección. Los detalles de nuestro proceso están disponibles en Github.
Fuentes analistas
Tecan Group AG está cubierta por 16 analistas. 8 de esos analistas presentaron las estimaciones de ingresos o ganancias utilizadas como datos para nuestro informe. Las estimaciones de los analistas se actualizan a lo largo del día.
| Analista | Institución |
|---|---|
| Harry Gillis | Berenberg |
| Delphine Le Louet | Bernstein |
| Susannah Ludwig | Bernstein |